Keiko Nakamura Selected Research

Keiko Nakamura Research Topics

Disease

4	Neoplasms (Cancer) 11/2020 - 06/2003
4	Multiple System Atrophy 06/2016 - 05/2015
2	Obesity 01/2021 - 01/2020
2	Infections 10/2020 - 01/2016
1	Malaria 03/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Lymphatic Metastasis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Periodontal Diseases (Periodontal Disease) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Overweight 01/2021
1	Cognitive Dysfunction 01/2021
1	Abscess 10/2020
1	Bone Resorption 06/2020
1	Wounds and Injuries (Trauma) 06/2020
1	Adenomatous Polyps 02/2020
1	Adenoma (Adenomas) 02/2020
1	Thrombosis (Thrombus) 01/2020
1	REM Sleep Behavior Disorder 01/2020
1	Neuronal intranuclear inclusion disease 05/2019
1	Myasthenia Gravis 05/2019
1	Blepharoptosis (Ptosis, Eyelid) 05/2019
1	Chronic Renal Insufficiency 05/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2018
1	Polyneuropathies (Polyneuropathy) 11/2017
1	Muscular Diseases (Myopathy) 02/2017
1	Granuloma 02/2017
1	Lewy Body Disease (Lewy Body Dementia) 06/2016
1	Malnutrition (Nutritional Deficiencies) 01/2016
1	Growth Disorders 01/2016
1	Mental Disorders (Mental Disorder) 01/2015
1	Tetanus 01/2015
1	Alcoholism (Alcohol Abuse) 01/2015
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 10/2014
1	Orthostatic Hypotension (Postural Hypotension) 10/2014
1	Hematuria 10/2014
1	Sporadic Creutzfeldt-Jakob Disease 08/2014
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2014
1	Pulmonary Edema 02/2014
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2012
1	Atrophy 08/2008
1	Anemia 09/2007
1	Rickets (Rachitis) 01/2007
1	Seizures (Absence Seizure) 10/2006
1	Alcohol-Related Disorders 07/2006
1	Hyperuricemia 02/2006
1	Gout 02/2006
1	Leukemia 06/2003
1	Shock 05/2003

Drug/Important Bio-Agent (IBA)

3	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 11/2020 - 01/2020
3	SynucleinsIBA 06/2016 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2017
1	Indicators and Reagents (Reagents)IBA 03/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	VaccinesIBA 10/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 06/2020
1	InflammasomesIBA 06/2020
1	MetalsIBA 06/2020
1	Plasminogen Activator Inhibitor 1IBA 01/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020
1	Cholinergic ReceptorsIBA 05/2019
1	Infliximab (Remicade)FDA Link 11/2017
1	PotassiumIBA 01/2016
1	LipidsIBA 10/2015
1	Illicit Drugs (Recreational Drugs)IBA 01/2015
1	Diflunisal (Dolobid)FDA Link 10/2014
1	Endopeptidase K (Proteinase K)IBA 08/2014
1	Prion ProteinsIBA 08/2014
1	NexusIBA 04/2014
1	Retinaldehyde (Retinal)IBA 08/2008
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2007
1	Sodium Channels (Sodium Channel)IBA 10/2006
1	Xanthine OxidaseIBA 02/2006
1	1- (3- cyano- 4- neopentyloxyphenyl)pyrazole- 4- carboxylic acidIBA 02/2006
1	Explosive Agents (Explosives)IBA 05/2003

Therapy/Procedure

3	Prenatal Care (Care, Prenatal) 01/2016 - 09/2007
2	Drug Therapy (Chemotherapy) 01/2012 - 06/2003
1	Activities of Daily Living (ADL) 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Oral Hygiene (Dental Hygiene) 01/2021
1	Long-Term Care 05/2018
1	Aftercare (After-Treatment) 10/2014
1	Lung Transplantation 02/2014
1	Mass Drug Administration 01/2012
1	Ambulatory Care (Outpatient Care) 07/2006
1	Combination Drug Therapy (Combination Chemotherapy) 06/2003